arrow
F

Francesca Ambrosi

military hospital ulm
H指数:19
被引数:856

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability

PD-L1 TPS对NSCLC病理反应的有限预测价值并非由观察者间变异引起

2026-06-010
OA
Lepidic and alveolar subepithelial squamous cell carcinoma: expansion of the concept of peripheral squamous cell carcinoma with proposal for revised terminology based on morphologic, immunophenotypic, and clinical analysis of 22 cases

基底样和肺泡亚上皮鳞状细胞癌:基于22例形态学、免疫表型和临床分析的周围性鳞状细胞癌概念的扩展及修订术语提案

2026-04-230
OAAI
Surgical outcomes after neoadjuvant chemoimmunotherapy for resectable NSCLC: a systematic review and meta-analysis

新辅助化疗免疫疗法治疗可切除非小细胞肺癌的手术结果:一项系统评价和荟萃分析

2026-04-160
PRE
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy

IL-1介导的炎症促进转移性播散以及对EGFR靶向疗法的抵抗

2026-04-080
OAAI
New insights into Nectin-4 expression in testicular choriocarcinoma and its potential treatment with Enfortumab Vedotin: analysis of a multi-institutional series and association with clinical-pathological features

睾丸绒毛膜癌中Nectin-4表达的新见解及其Enfortumab Vedotin的潜在治疗: 多机构系列分析及其与临床病理特征的关联

2026-01-210
PRE
Attrition with adjuvant, neoadjuvant, and perioperative immunotherapy-based treatment protocols in patients with resectable non-small-cell lung cancer. A meta-analysis of prospective trials

在可切除非小细胞肺癌患者中使用佐剂、新辅助和围手术期免疫治疗为基础的治疗方案的损耗情况。前瞻性试验的荟萃分析

2025-09-220
PREAI
Immunohistochemical expression of Nectin-4 and potential implications for enfortumab vedotin therapy in germ cell tumors of the testis: a preliminary study

Nectin-4的免疫组化表达及其在睾丸生殖细胞肿瘤中恩沃利单抗维多汀疗法中的潜在意义:一项初步研究

2025-09-110
PRE
Correction to: The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor

更正:在来源于生殖细胞的血管发生性间质病变中,FOXA2和HNF1β表达缺失,提示其可能遵循与肉瘤样卵黄囊瘤相似的进化途径。

2025-09-050
OA
Immunohistochemical expression of EZH2 in germ cell tumors of the testis: New insights into the genesis and epigenetic reprogramming of these fascinating tumors

睾丸生殖细胞肿瘤中EZH2的免疫组化表达:关于这些迷人肿瘤的起源和表观遗传重编程的新见解

2025-09-010
PRE
The absence of FOXA2 and HNF1β expression in vasculogenic mesenchymal lesions of germ cell origin suggests an evolutionary pathway similar to that of sarcomatoid yolk sac tumor

FOXA2和HNF1β在血管发生性间质病变中的缺失,提示其可能遵循与肉瘤样卵黄囊肿瘤相似的进化途径。

2025-08-180
PRE
Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region

揭示头颈部粘膜黑色素瘤的分子景观和临床相关分子异质性

2025-04-010
PRE
Characterization of testicular embryonic-type neuroectodermal tumor and embryonic-type neuroectodermal tissue admixed with mature neuro-glial tissue using a broad immunohistochemical panel

使用广泛的免疫组织化学小组表征睾丸胚胎型神经外胚层肿瘤和胚胎型神经外胚层组织与成熟神经胶质组织的混合

2024-09-110
PRE
Immunophenotypical assessment supports that post-chemotherapy glandular tumours of germ cell origin straddle between glandular yolk sac tumour and 'somatic-type' adenocarcinoma

免疫表型评估支持生殖细胞起源的化疗后腺体肿瘤跨越腺卵黄囊肿瘤和 “体细胞型” 腺癌之间

2024-07-011
PRE
Analysis of GATA3 and FOXA2 expression suggests that downregulation of genes involved in the maintenance of a mature yolk sac tumor phenotype may underlie sarcomatoid transformation

对GATA3和FOXA2表达的分析表明,参与维持成熟卵黄囊肿瘤表型的基因下调可能是肉瘤样转化的基础

2023-12-234
PRE
Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT

评估一系列机构的肾脏低度嗜酸细胞肿瘤 (LOT),并回顾LOT的突变情况

2023-10-176
OAAI